Nothing Special   »   [go: up one dir, main page]

Morris et al., 1994 - Google Patents

Characterization of humidity-dependent changes in crystal properties of a new HMG-CoA reductase inhibitor in support of its dosage form development

Morris et al., 1994

Document ID
215647569717743617
Author
Morris K
Newman A
Bugay D
Ranadive S
Singh A
Szyper M
Varia S
Brittain H
Serajuddin A
Publication year
Publication venue
International journal of pharmaceutics

External Links

Snippet

Humidity-dependent changes in the crystal properties of the disodium salt of a new HMG- CoA reductase inhibitor (SQ-33600) were characterized using a combination of gravimetric, thermal, and spectral techniques. The drug substance was found to exhibit rapid moisture …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing

Similar Documents

Publication Publication Date Title
Morris et al. Characterization of humidity-dependent changes in crystal properties of a new HMG-CoA reductase inhibitor in support of its dosage form development
Tishmack et al. Solid-state nuclear magnetic resonance spectroscopy-pharmaceutical applications
Zhang et al. Crystallization and transitions of sulfamerazine polymorphs
Offerdahl et al. Quantitation of crystalline and amorphous forms of anhydrous neotame using 13C CPMAS NMR spectroscopy
Marini et al. Drug-excipient compatibility studies by physico-chemical techniques; The case of Indomethacin
Rohrs et al. Tablet dissolution affected by a moisture mediated solid-state interaction between drug and disintegrant
CN102675281B (en) The polymorphic form of 3-(4-amino-1-oxo-1,3-DIHYDRO-ISOINDOL-2-base)-piperidines-2,6-diketone
Lutker et al. Polymorphs and hydrates of acyclovir
Bruni et al. Drug-excipient compatibility studies. Search of interaction indicators
Bobrovs et al. The reluctant polymorph: investigation into the effect of self-association on the solvent mediated phase transformation and nucleation of theophylline
Brittain et al. Solid-state NMR and IR for the analysis of pharmaceutical solids: polymorphs of fosinopril sodium
Giron et al. Solid-state of pharmaceutical compounds
Tong et al. A study of amorphous molecular dispersions of indomethacin and its sodium salt
Li et al. The solid‐state stability of amorphous quinapril in the presence of β‐cyclodextrins
Redman-Furey et al. Structural and analytical characterization of three hydrates and an anhydrate form of risedronate
Pan et al. Solid state characterization of azelnidipine–oxalic acid co-crystal and co-amorphous complexes: The effect of different azelnidipine polymorphs
Chang et al. Solid state characterization of dehydroepiandrosterone
Tandon et al. Art of synthesis of desired polymorphs: A review
Bauer et al. Role of an isomorphic desolvate in dissolution failures of an erythromycin tablet formulation
EP1951393A2 (en) Reaction co-crystallization of molecular complexes or co-crystals
US11584711B2 (en) 2,2,2-trifluoroacetic acid 1-(2,4-dimethylphenyl)-2-[(3-methoxyphenyl)methylene] method of making the same
Mirza et al. Solid‐state properties and relationship between anhydrate and monohydrate of baclofen
Ledwidge et al. Physicochemical characterization of diclofenac N-(2-hydroxyethyl) pyrrolidine: Anhydrate and dihydrate crystalline forms
Giron Monitoring of polymorphism–from detection to quantification
AU2023263403A1 (en) Polymorphs of [2-(1H-indol-3-yl)-1H-imidazol-4-yl](3,4,5-trimethoxyphenyl)methanone and its salts